Abstract
Background Epidemiological studies on body mass index (BMI) and non-invasive cardiovascular parameters are limited and inconsistent. To provide more informative data for further prevention and control, we examined associations between BMI, as well as overweight/obesity, and non-invasive cardiovascular parameters and their dose-response relationships in North Carolina Appalachian adults.
Methods A total of 71 participants were included in this analysis. Non-invasive cardiovascular parameters included carotid-femoral pulse wave velocity for measuring central arterial stiffness, augmentation index at 75 bpm for gauging peripheral arterial stiffness, ejection time for indicating left ventricular performance, and Buckberg index for measuring coronary microvascular circulation. Logistic regression models were used for analysis.
Results Every unit (kg/m2) increase in BMI was associated with a 25% statistically significant increased multivariable-adjusted odds of higher central arterial stiffness (odds ratio: 1.25; 95% confidence interval: 1.04-1.51), a 31% increased adjusted odds of higher peripheral arterial stiffness, a 23% statistically significant increased adjusted odds of worse left ventricular performance, and a 25% statistically significant increased adjusted odds of worse coronary microvascular circulation. Overweight/obesity was associated with a 532% statistically significant increased odds of higher arterial stiffness (6.32; 1.42-28.09), and a 704% statistically significant increased odds of worse left ventricular performance after adjusting for age, sex, physical activity, and body fat percentage.
Conclusion Increased BMI, especially overweight/obesity, was significantly associated with the increased risk of worse cardiovascular health, measured by non-invasive cardiovascular parameters. Efforts need to be focused on improving interventions to lower BMI/reduce overweight and obesity in North Carolina, especially in Appalachian populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study received approval from the Appalachian State University Institutional Review Board review (IRB# 21-0167).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the author MM. The data are not publicly available due to privacy or ethical restrictions.
